Cytarabine: Low-Dose, High-Dose, No Dose?
- 29 December 1983
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 309 (26) , 1637-1639
- https://doi.org/10.1056/nejm198312293092608
Abstract
Editorial from The New England Journal of Medicine — Cytarabine: Low-Dose, High-Dose, No Dose?Keywords
This publication has 13 references indexed in Scilit:
- Low Doses of Cytarabine in the Treatment of Myelodysplastic Syndrome and Acute Myeloid LeukemiaNew England Journal of Medicine, 1983
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983
- Remission of acute myelogenous leukemia in elderly patients with prior refractory dysmyelopoietic anemiaCancer, 1983
- Long-Term Marrow Culture Reveals Chromosomally Normal Hematopoietic Progenitor Cells in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1983
- Effect of polar organic compounds on leukemic cells: Butyrate-induced partial remission of acute myelogenous leukemia in a childCancer, 1983
- Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?British Journal of Haematology, 1982
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJournal of Clinical Investigation, 1982
- Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.The Journal of Experimental Medicine, 1981
- DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1979
- THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1978